NasdaqGM - Nasdaq Real Time Price USD
Wave Life Sciences Ltd. (WVE)
6.54
+0.08
+(1.24%)
At close: May 20 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -0.26 | -0.26 | -1 | -1.02 |
| Low Estimate | -0.31 | -0.31 | -1.13 | -1.26 |
| High Estimate | -0.1 | -0.16 | -0.77 | -0.67 |
| Year Ago EPS | -0.25 | -0.47 | -0.7 | -1 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 11 |
| Avg. Estimate | 14.07M | 14.59M | 62.5M | 64.44M |
| Low Estimate | 5M | 5M | 38.17M | -- |
| High Estimate | 36.99M | 28.99M | 94.2M | 140.5M |
| Year Ago Sales | 19.69M | -7.68M | 108.3M | 62.5M |
| Sales Growth (year/est) | -28.53% | 290.12% | -42.29% | 3.11% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.3 | -0.22 | -0.26 |
| EPS Actual | -0.25 | -0.47 | 0.27 | -0.29 |
| Difference | -0.03 | -0.17 | 0.5 | -0.03 |
| Surprise % | -13.64% | -54.46% | 220.00% | -13.48% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.26 | -0.26 | -1 | -1.02 |
| 7 Days Ago | -0.27 | -0.27 | -1.04 | -1.01 |
| 30 Days Ago | -0.25 | -0.22 | -0.92 | -1 |
| 60 Days Ago | -0.24 | -0.22 | -0.94 | -0.95 |
| 90 Days Ago | -0.25 | -0.22 | -0.97 | -0.73 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 1 | 2 | 3 |
| Up Last 30 Days | 2 | 1 | 1 | 3 |
| Down Last 7 Days | 4 | 5 | 5 | 4 |
| Down Last 30 Days | 4 | 5 | 5 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| WVE | -2.22% | 44.92% | -42.86% | -1.78% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Initiated | Cantor Fitzgerald: Overweight | 4/29/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/5/2025 |
| Initiated | Jefferies: Buy | 2/25/2025 |
| Maintains | Mizuho: Outperform to Outperform | 11/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
Related Tickers
KRRO Korro Bio, Inc.
16.18
+2.99%
PRQR ProQR Therapeutics N.V.
1.7600
+2.92%
SRRK Scholar Rock Holding Corporation
31.54
+4.58%
VYGR Voyager Therapeutics, Inc.
3.4000
-0.87%
SLDB Solid Biosciences Inc.
2.9500
+1.72%
RNA Avidity Biosciences, Inc.
31.64
+4.70%
ETNB 89bio, Inc.
9.03
+17.27%
RGNX REGENXBIO Inc.
10.00
+2.15%
JANX Janux Therapeutics, Inc.
25.40
+5.09%
QURE uniQure N.V.
15.31
+4.08%